These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9543821)

  • 1. Acute phase proteins as protective factors against the toxicity of tumor necrosis factor.
    Libert C
    Verh K Acad Geneeskd Belg; 1997; 59(6):515-23. PubMed ID: 9543821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice.
    Van Molle W; Libert C; Fiers W; Brouckaert P
    J Immunol; 1997 Oct; 159(7):3555-64. PubMed ID: 9317155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins.
    Van Molle W; Denecker G; Rodriguez I; Brouckaert P; Vandenabeele P; Libert C
    J Immunol; 1999 Nov; 163(10):5235-41. PubMed ID: 10553044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha1-Antitrypsin inhibits the lethal response to TNF in mice.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Immunol; 1996 Dec; 157(11):5126-9. PubMed ID: 8943423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
    Van Molle W; Van Roy M; Van Bogaert T; Dejager L; Van Lint P; Vanlaere I; Sekikawa K; Kollias G; Libert C
    Cancer Res; 2007 Aug; 67(15):7301-7. PubMed ID: 17671199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of and sensitization to the lethal effects of tumor necrosis factor.
    Brouckaert P; Libert C; Cauwels A; Everaerdt B; Van Molle W; Ameloot P; Gansemans Y; Grijalba B; Takahashi N; Truong MJ; Van Leuven P; Fiers W
    J Inflamm; 1995-1996; 47(1-2):18-26. PubMed ID: 8913926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.
    Wielockx B; Hochepied T; Staelens J; Van Molle W; Brouckaert P; Libert C
    Cytokine; 2001 Jul; 15(2):59-65. PubMed ID: 11500080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB.
    Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H
    Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective species specificity of tumor necrosis factor for toxicity in the mouse.
    Brouckaert P; Libert C; Everaerdt B; Fiers W
    Lymphokine Cytokine Res; 1992 Aug; 11(4):193-6. PubMed ID: 1420597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
    Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secretion of acute phase proteins and inflammatory cytokines during Trypanosoma congolense infection is not affected by the absence of the TNF-alpha gene.
    Kitani H; Yagi Y; Naessens J; Sekikawa K; Iraqi F
    Acta Trop; 2004 Sep; 92(1):35-42. PubMed ID: 15301973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor.
    Takahashi N; Waelput W; Guisez Y
    J Exp Med; 1999 Jan; 189(1):207-12. PubMed ID: 9874578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
    Curnis F; Sacchi A; Borgna L; Magni F; Gasparri A; Corti A
    Nat Biotechnol; 2000 Nov; 18(11):1185-90. PubMed ID: 11062439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-selective mutants of tumour necrosis factor in the therapy of cancer: preclinical studies.
    Brouckaert P; Ameloot P; Cauwels A; Everaerdt B; Libert C; Takahashi N; Van Molle W; Fiers W
    Circ Shock; 1994 Aug; 43(4):185-90. PubMed ID: 7895324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation.
    Künstle G; Hentze H; Germann PG; Tiegs G; Meergans T; Wendel A
    Hepatology; 1999 Nov; 30(5):1241-51. PubMed ID: 10534346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.